cms_NE: 12730

In collaboration with The Seattle Times, Big Local News is providing full-text nursing home deficiencies from Centers for Medicare & Medicaid Services (CMS). These files contain the full narrative details of each nursing home deficiency cited regulators. The files include deficiencies from Standard Surveys (routine inspections) and from Complaint Surveys. Complete data begins January 2011 (although some earlier inspections do show up). Individual states are provides as CSV files. A very large (4.5GB) national file is also provided as a zipped archive. New data will be updated on a monthly basis. For additional documentation, please see the README.

This data as json, copyable

rowid facility_name facility_id address city state zip inspection_date deficiency_tag scope_severity complaint standard eventid inspection_text filedate
12730 SKYVIEW AT BRIDGEPORT 285224 505 O STREET BRIDGEPORT NE 69336 2011-07-28 428 D     DMKP11 **NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Licensure Reference: 175 NAC 12-006.12B Based on interview and record review, the facility failed to ensure the consulting pharmacist identified the medication regime irregularity of the use of dual benzodiazepines in conjunction with a antihistamine at bedtime for Resident 39. Findings are: A review of Resident 39's face sheet (a cover sheet to a multipage document that contains demographic information, preferences, contact information, and limited medical information) dated 5/05/11 and located in the resident's chart, revealed the resident was admitted to the facility on [DATE] with [DIAGNOSES REDACTED]. A review of the physician's orders [REDACTED]. - Xanax (an antianxiety benzodiazepine medication) 0.25 mg (milligrams) at bedtime as needed for anxiety; prescribed 5/18/11. (Xanax was prescribed nightly from 4/27/11 to 5/18/11) -Restoril (a sedative/hypnotic benzodiazepine medication) 30 mg at bedtime as needed for insomnia; prescribed 5/19/11. (Restoril was prescribed nightly 4/23/11 to 5/19/11 and then reduced to 15mg on 7/13/11) -Tylenol PM (a combination of acetaminophen (an analgesic and antipyretic) and diphenhydramine (an antihistamine, often used for its sedative properties as a sleep aid) 500mg at bedtime; prescribed 5/27/11. A review of Resident 39's Medication Administration Record [MEDICATION ADMINISTRATION RECORD DETAILS REDACTED]. A review of the July 2011 MAR indicated [REDACTED] A review of the Consulting Pharmacist's Monthly Medication Regime Review sheet revealed the following: -5/5/2011 A recommendation for lab tests of a potassium level and thyroid stimulating hormone level. -6/14/11 No irregularities noted. -7/7/11 A recommendation for a gradual dose reduction for the Restoril. In an interview on 7/26/2011 at 4:45PM, the Consulting Pharmacist stated he/she was looking for medications that could be gradually reduced and/or medications that might be contra-indicated for that resident. The Consulting Pharmacist stated he/she felt the physician was aware of the medications the resident was on when the additions were made; and that having filled Resident 39's prescriptions prior to being admitted to the facility, may not have immediately recognized the use of two benzodiazepines as an irregularity. 2014-04-01